MedTrace Logo

Intravenous Vs. Intraosseous Vascular Access During Out-of-Hospital

NCT05205031 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1479

Last updated 2024-09-19

No results posted yet for this study

Summary

The "Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital Cardiac Arrest (IVIO)"-trial is an investigator-initiated, randomized, parallel group, patient and outcome assessor-blinded, superiority trial of intravenous vs. intraosseous vascular access during adult out-of-hospital cardiac arrest. The intraosseous group will be further randomized to humeral vs. tibial access. The trial will be conducted in the Central Denmark Region. The primary outcome will be sustained return of spontaneous circulation, and 762 patients will be included. Key secondary outcomes include survival at 30 days and survival at 30 days with a favorable neurological outcome.

Conditions

  • Cardiac Arrest

Interventions

DEVICE

Intraosseous access

Needle placed in the bone marrow.

DEVICE

Intravenous

Needle placed in a vein.

Sponsors & Collaborators

  • Central Denmark Region

    collaborator OTHER

  • University of Aarhus

    collaborator OTHER

  • Lars Wiuff Andersen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2024-05-05
Completion
2025-05-05

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205031 on ClinicalTrials.gov